Small-interfering RNA (siRNA) is both a powerful tool in research and a promising
therapeutic platform to modulate expression of disease-related genes. Malignant tumors are …

Small interfering RNAs (siRNA) have recently emerged as a new class of therapeutics with a
great potential to revolutionize the treatment of cancer and other diseases. A specifically …

Small interfering RNA (siRNA) drugs have been considered to treat various diseases in
major organs. However, siRNA drugs developed for cancer therapy are hindered from …

Small interfering ribonucleic acids (siRNAs) are originally recognized as an intermediate of
the RNA interference (RNAi) pathway. They can inhibit or silence various cellular pathways …

Recent progress in RNA biology has broadened the scope of therapeutic targets of RNA
drugs for cancer therapy. However, RNA drugs, typically small interfering RNAs (siRNAs) …

Small interfering RNA (siRNA) technology holds great promise as a therapeutic intervention
for targeted gene silencing in cancer and other diseases. However, in vivo systemic delivery …

Nanomedicine is a growing research field dealing with the creation and manipulation of
materials at a nanometer scale for the better treatment, diagnosis and imaging of diseases …

Small interfering RNA (siRNA) can selectively suppress the expression of disease-causing
genes, holding great promise in the treatment of human diseases, including malignant …

During recent decades there have been remarkable advances and profound changes in
cancer therapy. Many therapeutic strategies learned at the bench, including monoclonal …

RNA interference (RNAi) is a naturally occurring regulatory process that controls
posttranscriptional gene expression. Small interfering RNA (siRNA), a common form of RNAi …